PHILADELPHIA, June 23 (GenomeWeb News) - With two years of experience under its belt, it may be time for the US Food and Drug Administration to "rethink" its Voluntary Genomic Submission Guidelines program, according to Larry Lesko, director of the Office of Clinical Pharmacology at FDA's Center for Drug Evaluation and Research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.